The Valley Desk

NCT01026233 · Interventional trial

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

Overall registry status Completed

Phase 1

Conditions Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov